Qualitative Feedback on Food and Drug Administration Service Delivery

ICR 202311-0910-013

OMB: 0910-0697

Federal Form Document

Forms and Documents
Document
Name
Status
Supplementary Document
2023-11-27
Supplementary Document
2023-11-27
Justification for No Material/Nonsubstantive Change
2022-06-30
Supporting Statement B
2020-11-27
Supporting Statement A
2023-11-27
ICR Details
0910-0697 202311-0910-013
Received in OIRA 202206-0910-016
HHS/FDA Generic
Qualitative Feedback on Food and Drug Administration Service Delivery
Extension without change of a currently approved collection   No
Regular 11/28/2023
  Requested Previously Approved
36 Months From Approved 12/31/2023
15,752 15,752
8,491 8,491
0 0

The information collected from our customers and stakeholders will help ensure that users have an effective, efficient, and satisfying experience with FDA's programs. This feedback will provide insights into customer or stakeholder perceptions, experiences and expectations, provide an early warning of issues with service, or focus attention on areas where communication, training or changes in operations might improve delivery of products or services. These collections will allow for ongoing, collaborative and actionable communications between FDA and its customers and stakeholders. It will also allow feedback to contribute directly to the improvement of program management.

EO: EO 12862 Name/Subject of EO: Setting Customer Service Standards
  
None

Not associated with rulemaking

  88 FR 33889 05/25/2023
88 FR 82905 11/27/2023
No

0

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 15,752 15,752 0 -26,400 26,400 0
Annual Time Burden (Hours) 8,491 8,491 0 -14,725 14,725 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
Yes
Miscellaneous Actions
Based on a review of the information collection since our last request for OMB approval, we increased the number of respondents for focus groups, customer comment cards/forms, customer satisfaction surveys, and usability studies. This adjustment results in an overall burden increase of 6,234 hours.

$338,464
Yes Part B of Supporting Statement
    Yes
    No
No
No
No
No
Jonna Capezzuto 301 796-3794 jonnalynn.capezzuto@fda.hhs.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
11/28/2023


© 2024 OMB.report | Privacy Policy